Serum calcitonin negative Medullary thyroid carcinoma

41Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Medullary thyroid carcinomas (MTC) constitute about 5 to 7 % of thyroid neoplasms. They originate from parafollicular C cells which produce Calcitonin, a hormone which has an impact on calcium metabolism and represents the biochemical activity of MTC. In rare cases pre-operative serum calcitonin can be negative. Case presentation: We report on a 73-year-old female patient with a rare case of a serum calcitonin negative medullary thyroid carcinoma who suffered fulminant post-operative course and died of multiple metastasis. Conclusion: This case shows that in very rare cases MTCs do not secrete calcitonin making diagnosis and tumour follow-up difficult. To this date, only few reports describing this combination of circumstances were found in the English literature. © 2006 Sand et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Sand, M., Gelos, M., Sand, D., Bechara, F. G., Bonhag, G., Welsing, E., & Mann, B. (2006). Serum calcitonin negative Medullary thyroid carcinoma. World Journal of Surgical Oncology, 4. https://doi.org/10.1186/1477-7819-4-97

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free